{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T07:33:43Z","timestamp":1793172823384,"version":"4.5.0"},"reference-count":138,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T00:00:00Z","timestamp":1793059200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Toxicology Mechanisms and Methods"],"DOI":"10.1080\/15376516.2026.2749670","type":"journal-article","created":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T06:17:13Z","timestamp":1791958633000},"page":"1-34","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Molecular toxicological mechanisms of pharmaceutical nitrosamines: DNA damage, metabolic activation, carcinogenesis, and advanced analytical detection strategies"],"prefix":"10.1080","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-4086-2452","authenticated-orcid":false,"given":"Pradip","family":"Karale","sequence":"first","affiliation":[{"name":"Department of Pharmaceutics, Sanjivani College of Pharmaceutical Education & Research (Autonomous), Savitribai Phule Pune University","place":["Kopargaon, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishal","family":"Chabukswar","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, Sanjivani College of Pharmaceutical Education & Research (Autonomous), Savitribai Phule Pune University","place":["Kopargaon, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ishvari","family":"Avachar","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, Sanjivani College of Pharmaceutical Education & Research (Autonomous), Savitribai Phule Pune University","place":["Kopargaon, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilesh","family":"Chaudhari","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, Sanjivani College of Pharmaceutical Education & Research (Autonomous), Savitribai Phule Pune University","place":["Kopargaon, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raosaheb","family":"Shendge","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, Sanjivani College of Pharmaceutical Education & Research (Autonomous), Savitribai Phule Pune University","place":["Kopargaon, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,10,27]]},"reference":[{"key":"e_1_3_5_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.xphs.2016.03.019"},{"key":"e_1_3_5_3_1","unstructured":"Acevedo A. 2026. Determining N-nitrosamines in pharmaceutical preparations using LC\u2013MS\/MS | LCGC International. Available from: https:\/\/www.chromatographyonline.com\/view\/determining-n-nitrosamines-in-pharmaceutical-preparations-using-lc-ms-ms"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-025-03857-9"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1080\/10408347.2025.2512443"},{"key":"e_1_3_5_6_1","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1007\/978-1-4684-5134-4_97","volume-title":"Biological reactive intermediates III: mechanisms of action in animal models and human disease","author":"Archer MC","year":"1986","unstructured":"Archer MC, Silinskas KC, Zucker PF. 1986. Mechanism of organ specificity in nitrosamine carcinogenesis. In: Kocsis JJ, Jollow DJ, Witmer CM, Nelson JO, and Snyder R, editors. Biological reactive intermediates III: mechanisms of action in animal models and human disease. Springer US. p 1005\u20131011."},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1093\/mutage\/geag011"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.xphs.2023.03.022"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.joc.0c02774"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0968-0004(02)00010-5"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2024.105704"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mrgentox.2023.503685"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1005193313166"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.chemrestox.6b00384"},{"key":"e_1_3_5_15_1","unstructured":"Center for Drug Evaluation and Research. 2021. Updates on possible mitigation strategies to reduce the risk of nitrosamine drug substance-related impurities in drug products. FDA."},{"key":"e_1_3_5_16_1","unstructured":"Center for Drug Evaluation and Research. 2023. Recommended acceptable intake limits for nitrosamine drug substance-related impurities [online]. https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/recommended-acceptable-intake-limits-nitrosamine-drug-substance-related-impurities"},{"key":"e_1_3_5_17_1","unstructured":"Center for Drug Evaluation and Research. 2024a. Control of nitrosamine impurities in human drugs [online]. https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/control-nitrosamine-impurities-human-drugs"},{"key":"e_1_3_5_18_1","unstructured":"Center for Drug Evaluation and Research. 2024b. Bumetanide as a model NDSRI substrate: n -nitrosobumetanide impurity formation and its inhibition in bumetanide tablets. FDA."},{"key":"e_1_3_5_19_1","unstructured":"Center for Drug Evaluation and Research. 2026. CDER Nitrosamine impurity acceptable intake limits. FDA."},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.comtox.2023.100298"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tox.2024.153774"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1093\/etojnl\/vgae088"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2011.03.022"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1021\/bi301092c"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2011.06.002"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.oprd.3c00153"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.comtox.2021.100186"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.xphs.2024.11.003"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.3390\/biom12020185"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-2009-1098"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.chemrestox.4c00087"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00400754"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/em.22312"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.oprd.3c00404"},{"key":"e_1_3_5_35_1","unstructured":"EMA 2024. Nitrosamine impurities: guidance for marketing authorisation holders | European Medicines Agency (EMA) [online]. https:\/\/www.ema.europa.eu\/en\/human-regulatory-overview\/post-authorisation\/pharmacovigilance-post-authorisation\/referral-procedures-human-medicines\/nitrosamine-impurities\/nitrosamine-impurities-guidance-marketing-authorisation-holders"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.3390\/jox11030007"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24054684"},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16020331"},{"key":"e_1_3_5_39_1","unstructured":"FDA. 2026. CDER Nitrosamine Impurity Acceptable Intake Limits | FDA [online] https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/cder-nitrosamine-impurity-acceptable-intake-limits"},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2023.105505"},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.1002\/em.10036"},{"key":"e_1_3_5_42_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.oprd.3c00274"},{"key":"e_1_3_5_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2024.105763"},{"key":"e_1_3_5_44_1","doi-asserted-by":"publisher","DOI":"10.1002\/em.70009"},{"key":"e_1_3_5_45_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-1272-8"},{"key":"e_1_3_5_46_1","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/23.4.611"},{"key":"e_1_3_5_47_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1415266"},{"key":"e_1_3_5_48_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11120-008-9322-1"},{"key":"e_1_3_5_49_1","doi-asserted-by":"publisher","DOI":"10.1021\/jf010602h"},{"key":"e_1_3_5_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2024.105709"},{"key":"e_1_3_5_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.xphs.2023.01.021"},{"key":"e_1_3_5_52_1","doi-asserted-by":"publisher","DOI":"10.1186\/s41021-025-00349-5"},{"key":"e_1_3_5_53_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252111339"},{"key":"e_1_3_5_54_1","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2010.390"},{"key":"e_1_3_5_55_1","unstructured":"Iajps E. n.d. METHOD DEVELOPMENT AND VALIDATION OF FIVE NITROSAMINES IMPURITIES CONTENT IN TELMISARTAN DRUG SUBSTANCE BY GC-MS\/MS."},{"key":"e_1_3_5_56_1","doi-asserted-by":"publisher","DOI":"10.13005\/bpj\/3282"},{"key":"e_1_3_5_57_1","doi-asserted-by":"publisher","DOI":"10.1021\/jp206570n"},{"key":"e_1_3_5_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2024.105672"},{"key":"e_1_3_5_59_1","unstructured":"Jones K. 2026. HILIC-SPE and LC\u2013HRMS method used for N-nitrosamine detection in pharmaceuticals | LCGC International [online]. https:\/\/www.chromatographyonline.com\/view\/hilic-spe-and-lc-hrms-method-used-for-n-nitrosamine-detection-in-pharmaceuticals"},{"key":"e_1_3_5_60_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17223604"},{"key":"e_1_3_5_61_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.oprd.0c00462"},{"key":"e_1_3_5_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(84)90420-9"},{"key":"e_1_3_5_63_1","doi-asserted-by":"crossref","unstructured":"Korenjak M et al. 2024. Human cancer genomes harbor the mutational signature of tobacco-specific nitrosamines NNN and NNK.","DOI":"10.1101\/2024.06.28.600253"},{"key":"e_1_3_5_64_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.chemrestox.2c00380"},{"key":"e_1_3_5_65_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.chemrestox.4c00482"},{"key":"e_1_3_5_66_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.78.10.6489"},{"key":"e_1_3_5_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2024.105640"},{"key":"e_1_3_5_68_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12272-025-01581-x"},{"key":"e_1_3_5_69_1","doi-asserted-by":"publisher","DOI":"10.1186\/bcr3574"},{"key":"e_1_3_5_70_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph18189465"},{"key":"e_1_3_5_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpbao.2024.100027"},{"key":"e_1_3_5_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2023.105410"},{"key":"e_1_3_5_73_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2024.105730"},{"key":"e_1_3_5_74_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23094559"},{"key":"e_1_3_5_75_1","doi-asserted-by":"publisher","DOI":"10.1006\/taap.1999.8651"},{"key":"e_1_3_5_76_1","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2023.1137164"},{"key":"e_1_3_5_77_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mrfmmm.2008.06.003"},{"key":"e_1_3_5_78_1","doi-asserted-by":"publisher","DOI":"10.1021\/tx0501334"},{"key":"e_1_3_5_79_1","doi-asserted-by":"publisher","DOI":"10.1093\/mutage\/geae001"},{"key":"e_1_3_5_80_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.chemrestox.4c00234"},{"key":"e_1_3_5_81_1","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.122.026739"},{"key":"e_1_3_5_82_1","doi-asserted-by":"publisher","DOI":"10.3390\/cells11020288"},{"key":"e_1_3_5_83_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.xphs.2021.08.010"},{"key":"e_1_3_5_84_1","doi-asserted-by":"publisher","DOI":"10.1080\/10937400903158359"},{"key":"e_1_3_5_85_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2026.106155"},{"key":"e_1_3_5_86_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.dnarep.2007.07.015"},{"key":"e_1_3_5_87_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.xphs.2023.01.017"},{"key":"e_1_3_5_88_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2018.11.010"},{"key":"e_1_3_5_89_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2024.114498"},{"key":"e_1_3_5_90_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.talanta.2024.126752"},{"key":"e_1_3_5_91_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2023.106633"},{"key":"e_1_3_5_92_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2024.105762"},{"key":"e_1_3_5_93_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2025.106009"},{"key":"e_1_3_5_94_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.2c01498"},{"key":"e_1_3_5_95_1","doi-asserted-by":"publisher","DOI":"10.1016\/0165-6147(87)90164-7"},{"key":"e_1_3_5_96_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.chemrestox.4c00435"},{"key":"e_1_3_5_97_1","doi-asserted-by":"publisher","DOI":"10.1021\/tx300132k"},{"key":"e_1_3_5_98_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2026.156585"},{"issue":"3","key":"e_1_3_5_99_1","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.61096\/ijpar.v15i3.1159","article-title":"Nitrosamine drug-substance-related impurities (NDSRIs) in pharmaceuticals: formation chemistry, mechanistic pathways, analytical characterization, risk assessment, mitigation strategies and regulatory perspectives","volume":"15","author":"Satyanarayana D","year":"2026","unstructured":"Satyanarayana D, Mamatha K, Amulya N, Rama, Keerthipriya P. 2026. Nitrosamine drug-substance-related impurities (NDSRIs) in pharmaceuticals: formation chemistry, mechanistic pathways, analytical characterization, risk assessment, mitigation strategies and regulatory perspectives. IJPAR Journal. 15(3):1683\u20131701.","journal-title":"IJPAR Journal"},{"key":"e_1_3_5_100_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.chemrestox.4c00476"},{"key":"e_1_3_5_101_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00204-023-03560-x"},{"key":"e_1_3_5_102_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.namjnl.2026.100084"},{"issue":"1","key":"e_1_3_5_103_1","first-page":"73","article-title":"Attenuation of N-nitrosodimethylamine induced hepatotoxicity by Operculina turpethum in Swiss Albino mice","volume":"17","author":"Sharma V","year":"2014","unstructured":"Sharma V, Singh M. 2014. Attenuation of N-nitrosodimethylamine induced hepatotoxicity by Operculina turpethum in Swiss Albino mice. Iran J Basic Med Sci. 17(1):73\u201380.","journal-title":"Iran J Basic Med Sci"},{"key":"e_1_3_5_104_1","doi-asserted-by":"publisher","DOI":"10.5487\/TR.2017.33.2.079"},{"key":"e_1_3_5_105_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00204-025-04103-2"},{"key":"e_1_3_5_106_1","doi-asserted-by":"publisher","DOI":"10.37349\/etat.2025.1002335"},{"key":"e_1_3_5_107_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.chemrestox.3c00327"},{"key":"e_1_3_5_108_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2023.105403"},{"key":"e_1_3_5_109_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00402770"},{"key":"e_1_3_5_110_1","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kfae012"},{"key":"e_1_3_5_111_1","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aee8680"},{"issue":"2","key":"e_1_3_5_112_1","article-title":"Metabolic Activation and carcinogenesis of tobacco-specific Nitrosamine N\u2019-Nitrosonornicotine (NNN): a density function theory and molecular docking study","volume":"16","author":"Tang F","year":"2019","unstructured":"Tang, F et al. 2019. Metabolic Activation and carcinogenesis of tobacco-specific Nitrosamine N\u2019-Nitrosonornicotine (NNN): a density function theory and molecular docking study. Int J Environ Res Public Health. 16(2):178.","journal-title":"Int J Environ Res Public Health"},{"key":"e_1_3_5_113_1","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/21.8.1559"},{"key":"e_1_3_5_114_1","doi-asserted-by":"publisher","DOI":"10.1093\/mutage\/gead033"},{"key":"e_1_3_5_115_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.chemrestox.2c00199"},{"key":"e_1_3_5_116_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2020.104749"},{"key":"e_1_3_5_117_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2022.105247"},{"key":"e_1_3_5_118_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharma.2026.03.006"},{"key":"e_1_3_5_119_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpha.2023.12.009"},{"key":"e_1_3_5_120_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.105.091306"},{"key":"e_1_3_5_121_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.chemrestox.5c00310"},{"key":"e_1_3_5_122_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA118.007358"},{"key":"e_1_3_5_123_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.xphs.2024.12.025"},{"key":"e_1_3_5_124_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms14048381"},{"key":"e_1_3_5_125_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.chemrestox.2c00217"},{"key":"e_1_3_5_126_1","unstructured":"WHO. 2026. Update on N-nitrosamine impurities | WHO - Prequalification of Medical Products (IVDs Medicines Vaccines and Immunization Devices Vector Control) [online]. https:\/\/extranet.who.int\/prequal\/news\/update-n-nitrosamine-impurities"},{"key":"e_1_3_5_127_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsomega.1c00982"},{"key":"e_1_3_5_128_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsps.2022.12.010"},{"key":"e_1_3_5_129_1","doi-asserted-by":"publisher","DOI":"10.1016\/0009-2797(78)90079-0"},{"key":"e_1_3_5_130_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1976.44"},{"key":"e_1_3_5_131_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28217405"},{"key":"e_1_3_5_132_1","doi-asserted-by":"publisher","DOI":"10.1021\/tx0497696"},{"key":"e_1_3_5_133_1","doi-asserted-by":"publisher","DOI":"10.1002\/bmc.70591"},{"key":"e_1_3_5_134_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mrgentox.2024.503763"},{"key":"e_1_3_5_135_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.envint.2022.107423"},{"key":"e_1_3_5_136_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-026-01230-1"},{"key":"e_1_3_5_137_1","doi-asserted-by":"publisher","DOI":"10.1002\/em.22615"},{"key":"e_1_3_5_138_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpbao.2025.100084"},{"key":"e_1_3_5_139_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.xphs.2023.07.014"}],"container-title":["Toxicology Mechanisms and Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/15376516.2026.2749670","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/15376516.2026.2749670","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/15376516.2026.2749670","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T06:47:11Z","timestamp":1793170031000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/15376516.2026.2749670"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,27]]},"references-count":138,"alternative-id":["10.1080\/15376516.2026.2749670"],"URL":"https:\/\/doi.org\/10.1080\/15376516.2026.2749670","relation":{},"ISSN":["1537-6516","1537-6524"],"issn-type":[{"value":"1537-6516","type":"print"},{"value":"1537-6524","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,27]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=itxm20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=itxm20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-07-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-10-09","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-10-10","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-10-27","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}